One very promising approach for the treatment of NAFLD and NASH that has recently emerged is activation of the transcription factor nuclear factor-erythroid 2-related factor 2 (NRF2). The gene discussed is NFE2L2; the disease is metabolic dysfunction-associated steatohepatitis.